{"id":"metformin-rosuvastatin","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Gastrointestinal disturbance (metformin)"},{"rate":"3-5","effect":"Muscle pain or myalgia (rosuvastatin)"},{"rate":"1-3","effect":"Elevated liver enzymes"},{"rate":"5-10","effect":"Headache"},{"rate":"<0.1","effect":"Lactic acidosis (metformin, rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin is a biguanide that decreases hepatic gluconeogenesis and improves peripheral insulin sensitivity, primarily used in type 2 diabetes. Rosuvastatin is a statin that competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, reducing LDL cholesterol and cardiovascular risk. The combination addresses both glycemic control and lipid management in patients with concurrent diabetes and dyslipidemia.","oneSentence":"This combination reduces blood glucose through metformin's inhibition of hepatic glucose production and increases insulin sensitivity, while rosuvastatin lowers cholesterol by inhibiting HMG-CoA reductase.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:21:05.687Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus with dyslipidemia"},{"name":"Cardiovascular risk reduction in patients with diabetes and elevated cholesterol"}]},"trialDetails":[{"nctId":"NCT07223671","phase":"PHASE1","title":"Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2025-12-31","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT06899061","phase":"PHASE1","title":"Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-25","conditions":"Advanced Solid Malignancies","enrollment":41},{"nctId":"NCT07372625","phase":"PHASE1","title":"A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.","status":"RECRUITING","sponsor":"PMV Pharmaceuticals, Inc","startDate":"2026-02-04","conditions":"TP53 Y220C Mutation, Advanced Solid Tumors","enrollment":14},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT07446400","phase":"PHASE1","title":"A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together","status":"NOT_YET_RECRUITING","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2026-03-20","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT07222098","phase":"PHASE1","title":"A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-19","conditions":"Healthy","enrollment":16},{"nctId":"NCT05741372","phase":"NA","title":"A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2023-09-07","conditions":"Liver Cirrhosis","enrollment":28},{"nctId":"NCT06504862","phase":"PHASE1","title":"A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-08-20","conditions":"Healthy","enrollment":32},{"nctId":"NCT05064488","phase":"PHASE1","title":"Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2021-10-04","conditions":"Healthy","enrollment":40},{"nctId":"NCT06813924","phase":"PHASE1","title":"A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2025-02-06","conditions":"Healthy Volunteers Sickle Cell Disease, Thalassemia","enrollment":37},{"nctId":"NCT06071442","phase":"PHASE1","title":"Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2024-01-17","conditions":"Healthy Participants","enrollment":60},{"nctId":"NCT06779253","phase":"PHASE1","title":"A Study to Investigate The Effect of Pimicotinib on The Pharmacokinetics of Metformin, Fexofenadine and Rosuvastatin In Healthy Subjects","status":"COMPLETED","sponsor":"Abbisko Therapeutics Co, Ltd","startDate":"2025-03-14","conditions":"Healthy Subjects","enrollment":39},{"nctId":"NCT04008186","phase":"PHASE1","title":"A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone","status":"COMPLETED","sponsor":"Biogen","startDate":"2019-06-14","conditions":"Healthy Adult Subjects","enrollment":61},{"nctId":"NCT06335134","phase":"PHASE1","title":"A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin","status":"COMPLETED","sponsor":"Hangzhou Sciwind Biosciences Co., Ltd.","startDate":"2023-07-14","conditions":"Healthy Volunteers","enrollment":57},{"nctId":"NCT06160414","phase":"PHASE1","title":"A Study to Investigate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult Participants","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2023-04-12","conditions":"Healthy","enrollment":20},{"nctId":"NCT05828303","phase":"PHASE1","title":"A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors","status":"WITHDRAWN","sponsor":"Turning Point Therapeutics, Inc.","startDate":"2024-11-15","conditions":"Advanced Solid Tumor, Metastatic Solid Tumor","enrollment":""},{"nctId":"NCT06416800","phase":"PHASE1","title":"A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2024-06-19","conditions":"Healthy Participants","enrollment":71},{"nctId":"NCT02611518","phase":"PHASE1","title":"A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-04-05","conditions":"Healthy","enrollment":32},{"nctId":"NCT05981365","phase":"PHASE1","title":"Voxelotor CYP and Transporter Cocktail Interaction Study","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-04-17","conditions":"Sickle Cell Disease","enrollment":44},{"nctId":"NCT05657613","phase":"PHASE1","title":"Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects","status":"COMPLETED","sponsor":"CTI BioPharma","startDate":"2023-01-03","conditions":"Drug Interactions","enrollment":60},{"nctId":"NCT06247748","phase":"PHASE1","title":"Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects","status":"COMPLETED","sponsor":"Beijing Dongfang Biotech Co., Ltd.","startDate":"2023-10-19","conditions":"Diabetes Mellitus, Type 2, Overweight","enrollment":28},{"nctId":"NCT06515652","phase":"NA","title":"To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syndrome","status":"RECRUITING","sponsor":"Hamdard University","startDate":"2023-09-01","conditions":"Metabolic Syndrome","enrollment":200},{"nctId":"NCT06460896","phase":"NA","title":"Analysis of the Influence of Gastric By-Pass on the Pharmacokinetics of Common Drugs","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-09","conditions":"Bypass Bariatric Surgery","enrollment":64},{"nctId":"NCT05615012","phase":"PHASE1","title":"A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2022-11-11","conditions":"Healthy Participants","enrollment":76},{"nctId":"NCT04931147","phase":"PHASE1","title":"A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers","status":"COMPLETED","sponsor":"Redx Pharma Ltd","startDate":"2021-05-13","conditions":"Fibrosis, Inflammation, Idiopathic Pulmonary Fibrosis","enrollment":90},{"nctId":"NCT02574845","phase":"PHASE1","title":"DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2015-10-12","conditions":"Healthy","enrollment":18},{"nctId":"NCT02854527","phase":"PHASE1","title":"Transporter Cocktail Mutual Interaction","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2016-08-22","conditions":"Healthy","enrollment":30},{"nctId":"NCT03307252","phase":"PHASE1","title":"This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2017-10-25","conditions":"Healthy","enrollment":45},{"nctId":"NCT02231931","phase":"PHASE1","title":"Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-09-01","conditions":"Healthy","enrollment":24},{"nctId":"NCT04590937","phase":"PHASE1","title":"A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-10-20","conditions":"Healthy","enrollment":15},{"nctId":"NCT05768360","phase":"PHASE1","title":"A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-04-25","conditions":"Healthy Male Subjects","enrollment":6},{"nctId":"NCT05893849","phase":"","title":"Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2023-03-28","conditions":"Aging","enrollment":624},{"nctId":"NCT03772262","phase":"EARLY_PHASE1","title":"Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach","status":"COMPLETED","sponsor":"Washington State University","startDate":"2018-04-05","conditions":"Interaction Drug Food","enrollment":16},{"nctId":"NCT03907423","phase":"NA","title":"Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin","status":"COMPLETED","sponsor":"Rehab Werida","startDate":"2019-04-01","conditions":"Diabetes Mellitus, Type 2","enrollment":70},{"nctId":"NCT05236530","phase":"PHASE1","title":"Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-03-09","conditions":"Malaria","enrollment":48},{"nctId":"NCT04428086","phase":"PHASE1","title":"A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2020-07-27","conditions":"Solid Tumor, Adult","enrollment":19},{"nctId":"NCT05076877","phase":"PHASE1","title":"A Study of Lazertinib (JNJ-73841937) in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-17","conditions":"Healthy","enrollment":20},{"nctId":"NCT04268394","phase":"PHASE1","title":"A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677","status":"COMPLETED","sponsor":"Celgene","startDate":"2020-03-13","conditions":"Healthy Volunteer","enrollment":48},{"nctId":"NCT04621669","phase":"PHASE1","title":"Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2020-11-19","conditions":"Drug-drug Interaction,SHR3680","enrollment":18},{"nctId":"NCT04233437","phase":"PHASE1","title":"Drug-Drug Interaction Study of MLC1501 Using Cocktail of Drugs Acting as Sensitive Clinical Probes/Substrates of Cytochrome P450 Isoenzymes and Transporters in Healthy Subjects","status":"COMPLETED","sponsor":"Moleac Pte Ltd.","startDate":"2020-02-10","conditions":"Stroke","enrollment":27},{"nctId":"NCT04231435","phase":"PHASE1","title":"Influence of Fedratinib on the Pharmacokinetics of the Transporter Probe Substrates Digoxin, Rosuvastatin, and Metformin","status":"COMPLETED","sponsor":"Celgene","startDate":"2019-12-18","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT03690778","phase":"PHASE1","title":"The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.","status":"COMPLETED","sponsor":"Jeil Pharmaceutical Co., Ltd.","startDate":"2018-10-04","conditions":"Diabetes, Hyperlipidemias","enrollment":42},{"nctId":"NCT03363815","phase":"PHASE1","title":"A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Celgene","startDate":"2017-12-04","conditions":"Heathy Volunteer","enrollment":56},{"nctId":"NCT02586129","phase":"PHASE3","title":"Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2015-11-04","conditions":"Dyslipidemia, Type II Diabetes","enrollment":249},{"nctId":"NCT02827903","phase":"PHASE3","title":"Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia","status":"COMPLETED","sponsor":"Jeil Pharmaceutical Co., Ltd.","startDate":"2016-01-15","conditions":"Type 2 Diabetes, Dyslipidemia","enrollment":237},{"nctId":"NCT02449187","phase":"PHASE1","title":"Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Jeil Pharmaceutical Co., Ltd.","startDate":"2017-08-02","conditions":"Diabetes, Hyperlipidemia","enrollment":16},{"nctId":"NCT02982798","phase":"PHASE1","title":"The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Jeil Pharmaceutical Co., Ltd.","startDate":"2017-07-06","conditions":"Diabetes, Hyperlipidemia","enrollment":40},{"nctId":"NCT02186483","phase":"PHASE1","title":"Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin","status":"COMPLETED","sponsor":"Jeil Pharmaceutical Co., Ltd.","startDate":"2014-08","conditions":"Hyperlipidemia, Diabetes","enrollment":24},{"nctId":"NCT01992211","phase":"PHASE1","title":"Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin","status":"COMPLETED","sponsor":"BC World Pharm Co. Ltd.","startDate":"2016-12-15","conditions":"Healthy","enrollment":35},{"nctId":"NCT03204058","phase":"PHASE2, PHASE3","title":"Locally Delivered Metformin & Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis","status":"COMPLETED","sponsor":"Government Dental College and Research Institute, Bangalore","startDate":"2016-02-10","conditions":"Chronic Periodontitis","enrollment":90},{"nctId":"NCT02125227","phase":"PHASE1","title":"Phase 1 Clinical Trial to Investigate the Effect on the Pharmacokinetics of YH14755 Compared to Co-administration of Rosuvastatin and Metformin SR in Healthy Volunteers","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2014-04","conditions":"Healthy","enrollment":56},{"nctId":"NCT02011633","phase":"PHASE1","title":"Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2013-10","conditions":"Diabetes Mellitus","enrollment":72},{"nctId":"NCT02026817","phase":"PHASE1","title":"Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2013-12","conditions":"Diabetes Mellitus","enrollment":36},{"nctId":"NCT01929512","phase":"PHASE1","title":"Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2013-06","conditions":"Diabetes Mellitus","enrollment":72},{"nctId":"NCT01775579","phase":"PHASE1","title":"Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2013-01","conditions":"Diabetes Mellitus","enrollment":36},{"nctId":"NCT01526317","phase":"PHASE1","title":"A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2011-12","conditions":"Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR","enrollment":36}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BLOOD GLUCOSE FLUCTUATION"},{"count":1,"reaction":"BLOOD GLUCOSE INCREASED"}],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Metformin + Rosuvastatin","genericName":"Metformin + Rosuvastatin","companyName":"Jeil Pharmaceutical Co., Ltd.","companyId":"jeil-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination reduces blood glucose through metformin's inhibition of hepatic glucose production and increases insulin sensitivity, while rosuvastatin lowers cholesterol by inhibiting HMG-CoA reductase. Used for Type 2 diabetes mellitus with dyslipidemia, Cardiovascular risk reduction in patients with diabetes and elevated cholesterol.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}